On December 21, the 9th People's Safe Drug Survey and Appraisal was held in Foshan, Guangdong by Pharmaceutical Administration of National Health and Family Planning Commission, Jiankangbao and Well-Being. YRPG'S Weidi (Pantoprazole Sodium for Injection) won People's Reliable Medicine and YRPG won Contribution Prize for China's Medicine Undertaking.
This survey and appraisal, themed "Public Trust and Supply Guarantee", has collected over 83,977 questionnaires. They awarded People's Reliable Medicine and Contribution Prizes through targeted analysis based on the data of information platform in procurement information centers from different provinces and review on the results from doctors and the general public. They gave prizes to reliable, safe, affordable and well-reputed products. The survey covered the whole of the daily medicine use, and its fairness and authority has won public consensus.
Jiankangbao is a newspaper owned by the state and it has the largest volume and highest authority in its field in China. The survey launched by the newspaper has been held nine times since its debut in 2004. The survey has won support from the Pharmaceutical Administration of National Health and Family Planning Commission and has become an influential brand in the pharmaceutical media.
Weidi was the drug for acute upper gastrointestinal hemorrhage caused by duodenal ulcer, ulcer, AGML, etc., which was launched by YRPG in 2002. Its sale has been climbing since its launch and has been awarded the China's Good Product, Jiangsu Renowned Product, Jiangsu Separate Priced Product and High-Tech Product. The product is acknowledged in pharmaceutical industry.